|
1
|
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.
|
Int Orthop
|
2013
|
1.00
|
|
2
|
Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin.
|
Pharmacol Res
|
2012
|
0.83
|
|
3
|
Olive oil biophenols and women's health.
|
Med Glas (Zenica)
|
2012
|
0.80
|
|
4
|
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
|
J Med Chem
|
2012
|
0.80
|
|
5
|
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
|
J Med Chem
|
2007
|
0.79
|
|
6
|
Synthesis and properties of macrolones characterized by two ether bonds in the linker.
|
Bioorg Med Chem
|
2010
|
0.76
|
|
7
|
Porphyrins as new endogenous anti-inflammatory agents.
|
Eur J Pharmacol
|
2012
|
0.75
|
|
8
|
Macrolide Hybrid Compounds: Drug Discovery Opportunities in Anti-Infective and Anti-Inflammatory Area.
|
Curr Top Med Chem
|
2016
|
0.75
|
|
9
|
Tebrophen--an old polyphenol drug with anticancer potential.
|
Molecules
|
2012
|
0.75
|